ND

Narinder Devgan

Director Designated Partner DIN 03430762
DIN 03430762 First appointment May 2012 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Narinder Devgan

Data last updated:

Narinder Devgan was a Designated Partner at Wellista Healthcare Llp (2015–2020) and Director at Quanpro Consulting Private Limited (from 2012). The companies operate in Pharma.

DIN 03430762
Primary Designation Designated Partner
Industry Pharma
First Appointment 08 May 2012
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner26 Aug 20152015Strike Off
Quanpro Consulting Private Limited U74140DL2012PTC235465
Director08 May 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Quanpro Consulting Private Limited
Wellista Healthcare Llp
Premium access

Shareholding and investment profile for Narinder Devgan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narinder Devgan

Narinder Devgan was first appointed on 08 May 2012 as Director at Quanpro Consulting Private Limited. The most recent appointment on record is 26 Aug 2015 at Wellista Healthcare Llp.

Narinder Devgan held 2 earlier board appointments: Wellista Healthcare Llp (Designated Partner, 26 Aug 2015 to 31 Aug 2020); Quanpro Consulting Private Limited (Director, from 08 May 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available